Europe Hematology Market - 2022-2030
The Europe Hematology Market was valued at USD 2,226.74 million in 2022 and is anticipated to reach USD 3,562.89 million by 2030, at a CAGR of 0.062 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Europe Hematology Market.
This report delivers a comprehensive overview of the Europe Hematology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Hematology Market. The Europe Hematology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
Europe Hematology Market Scope:
By Product Type
This report delivers a comprehensive overview of the Europe Hematology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Hematology Market. The Europe Hematology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Europe Hematology Market.
This report delivers a comprehensive overview of the Europe Hematology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Hematology Market. The Europe Hematology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
Europe Hematology Market Scope:
By Product Type
- Hematology Analyzers
- Flow Cytometers
- Coagulation Analyzers
- Slide Stainers
- Centrifuges
- Hemoglobinometers
- Others
- Coagulation Reagents
- Flow Cytometry Reagents
- Immuno-hematology Reagents
- Others
- Drug Testing
- Auto-immune Diseases
- Cancer
- Diabetes Mellitus
- Infectious Diseases
- Others
- Hospitals and Clinics
- Diagnostic Centers
- Homecare settings
- Others
- Abbott
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Danaher
- Bio-Rad Laboratories, Inc.
- EKF Diagnostics Holdings plc
- HORIBA Medical
- Diatron
- Biosystems S.A.
- Siemens
- NIHON KOHDEN CORPORATION(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Europe Hematology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Europe Hematology Market. The Europe Hematology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising prevalence of chronic blood disorders
4.1.1.2. More product launches and product approvals would fuel market expansion
4.1.2. Restraints:
4.1.2.1. The high cost of the instruments and the low adoption of hematology analyzers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Hematology Analyzers
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Flow Cytometers
7.4. Coagulation Analyzers
7.5. Slide Stainers
7.6. Centrifuges
7.7. Hemoglobinometers
7.8. Others
8. BY REAGENT TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Reagent Type
8.1.2. Market Attractiveness Index, By Reagent Type
8.2. Coagulation Reagents
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Flow Cytometry Reagents
8.4. Immuno-hematology Reagents
8.5. Others
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By End-user
9.2. Drug Testing
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Auto-immune Diseases
9.4. Cancer
9.5. Diabetes Mellitus
9.6. Infectious Diseases
9.7. Others
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Diagnostic Centers
10.4. Homecare settings
10.5. Others
11. BY COUNTRY
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2022-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
11.1.2. Market Attractiveness Index, By Country
11.2. Germany
11.2.1. Introduction
11.2.2. Key Country-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3. The U.K.
11.3.1. Introduction
11.3.2. Key Country-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4. France
11.4.1. Introduction
11.4.2. Key Country-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5. Italy
11.5.1. Introduction
11.5.2. Key Country-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.6. Spain
11.6.1. Introduction
11.6.2. Key Country-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.7. Rest of Europe
11.7.1. Introduction
11.7.2. Key Country-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Products Benchmarking
12.4. List of Key Companies to Watch
13. COMPANY PROFILES
13.1. Abbott
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.3. Danaher
13.4. Bio-Rad Laboratories, Inc.
13.5. EKF Diagnostics Holdings plc
13.6. HORIBA Medical
13.7. Diatron
13.8. Biosystems S.A.
13.9. Siemens
13.10. NIHON KOHDEN CORPORATION(*LIST NOT EXHAUSTIVE)
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Application
14.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising prevalence of chronic blood disorders
4.1.1.2. More product launches and product approvals would fuel market expansion
4.1.2. Restraints:
4.1.2.1. The high cost of the instruments and the low adoption of hematology analyzers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Hematology Analyzers
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Flow Cytometers
7.4. Coagulation Analyzers
7.5. Slide Stainers
7.6. Centrifuges
7.7. Hemoglobinometers
7.8. Others
8. BY REAGENT TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Reagent Type
8.1.2. Market Attractiveness Index, By Reagent Type
8.2. Coagulation Reagents
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Flow Cytometry Reagents
8.4. Immuno-hematology Reagents
8.5. Others
9. BY APPLICATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By End-user
9.2. Drug Testing
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Auto-immune Diseases
9.4. Cancer
9.5. Diabetes Mellitus
9.6. Infectious Diseases
9.7. Others
10. BY END USER
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Diagnostic Centers
10.4. Homecare settings
10.5. Others
11. BY COUNTRY
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2022-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
11.1.2. Market Attractiveness Index, By Country
11.2. Germany
11.2.1. Introduction
11.2.2. Key Country-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3. The U.K.
11.3.1. Introduction
11.3.2. Key Country-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4. France
11.4.1. Introduction
11.4.2. Key Country-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5. Italy
11.5.1. Introduction
11.5.2. Key Country-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.6. Spain
11.6.1. Introduction
11.6.2. Key Country-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.7. Rest of Europe
11.7.1. Introduction
11.7.2. Key Country-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Reagent Type
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. COMPETITIVE LANDSCAPE
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Products Benchmarking
12.4. List of Key Companies to Watch
13. COMPANY PROFILES
13.1. Abbott
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.3. Danaher
13.4. Bio-Rad Laboratories, Inc.
13.5. EKF Diagnostics Holdings plc
13.6. HORIBA Medical
13.7. Diatron
13.8. Biosystems S.A.
13.9. Siemens
13.10. NIHON KOHDEN CORPORATION(*LIST NOT EXHAUSTIVE)
14. DATAM INTELLIGENCE
14.1. Appendix
14.2. About Us and Application
14.3. Contact Us
